Stockreport

Plus Therapeutics Expands CNSide Assay Platform to State of California [Yahoo! Finance]

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a cl [Read more]